Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Chemesis International Inc. (C:CSI)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for CSI within the last 6 months
See all filings within the past 6 months

Company News

Feb 04, 2020 18:50 ET
Chemesis International Inc. Provides Corporate Update
VANCOUVER, BC / ACCESSWIRE / February 4, 2020 / Chemesis International Inc. (CSE:CSI)(OTCQB:CADMF)(FRA:CWAB) (the "Company" or "Chemesis"), is pleased to announce, further to its news release dated January 27, 2020, that the Puerto Rico Department of Health (the "DHPR"), as a result of the previously announced favourable judgment from the Puerto Rico Superior Court, San Juan (the "Decision") (please see the news release dated January 17, 2020), has reinstated all cannabis cultivation and cannabis manufacturing licenses
Read full article
Jan 27, 2020 09:00 ET
Chemesis International Inc. Provides Corporate Update
VANCOUVER, BC / ACCESSWIRE / January 27, 2020 / Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the "Company" or "Chemesis"), announces, further to its news release dated January 17, 2019, that the Puerto Rico Department of Health has commenced an appeal of the favourable judgment (the "Decision") obtained by the Company from the Puerto Rico Superior Court, San Juan, in respect of the certain cannabis licenses ("Licenses") held by its subsidiary, Natural Ventures PR, LLC ("Natural Ventures&q
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 31, 202018,816-103,721
Jan 15, 2020122,53771,277
Dec 31, 201951,260-416,796
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Chemesis International Inc is a Canada-based company engaged in canabis business sector. The Company is a licensed producer and manufacturer of medical and recreational cannabis and it is focused on cultivation, extraction, distribution and retail of cannabis. The Company operates within California, Puerto Rico, and Columbia. By providing knowledge, structure and leadership, The Company grows new markets and revenues within Cultivation, Manufacturing, Distribution and Retail Sales. It offers it's clients all types of extractions, formulations and products, specializing in Butane Hash Oil Extraction, Alchohol Extraction, and Carbon Dioxide Extraction and has the capacity to process over 2000 pounds of raw material per day.

See business summary


Search (past week) for $CSI.CA